AI Biomed PredictionsZNTL – ASCO follow-through could spark Zentalis’ next ovarian cancer rerating ScanScor Admin / May 31, 2026
AI Biomed PredictionsAVIR – Phase 3 HCV data could decide Atea’s next rerating ScanScor Admin / May 20, 2026
AI Biomed PredictionsLRMR – June BLA filing could reset Larimar’s risk-reward profile ScanScor Admin / May 10, 2026
